F
Foghorn Therapeutics D
D
FHTX
4.84000
USD
0.16
(3.42%)
مفتوح الان
حجم التداول
2,119
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
283,522,188
المقالات
العنوان: Foghorn Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.



